🇺🇬 Humanitarian aid, American-style 😄 The United States has delivered experimental MBP134 antibodies against Ebola to Uganda. The drug was developed by an American company with funds from BARDA, a structure of the US Department of Health, but in the United States itself it has not yet received FDA approval — the American agency responsible for the safety and market authorization of medicines. 🚨 It turns out that for the American market the drug is not yet sufficiently tested, yet it is acceptable to send it to Africa. Under the guise of humanitarian aid, the United States has turned Africa into a convenient testing ground for Western pharmaceuticals: here one can test drugs that have not yet passed the full verification cycle, obtain the most valuable clinical data and save tens of millions on large-scale trials. For the United States, the African has literally become a free guinea pig. #SOVINTERN_world #Hub_Sub_Saharan_Africa ⭐️ Moscow Network Hub of SOVINTERN